Cocrystal Pharma (COCP) Short term Debt (2010 - 2013)
Cocrystal Pharma (COCP) posted Short term Debt of $206042.0 for Q2 2013, little changed sequentially from $206040.0 in Q1 2013, and down 5.38% YoY from $217755.0 in Q2 2012.
Cocrystal Pharma (COCP) Short term Debt (2010 - 2013) Analysis & Trends
Cocrystal Pharma has reported Short term Debt for 4 years, with the latest figure at $206042.0 in Q2 2013.
- Quarterly Short term Debt fell 5.38% year-over-year to $206042.0 in Q2 2013, while the trailing twelve-month figure through Jun 2013 was $206042.0 (down 5.38% YoY) and the FY2012 annual result came in at $181752.0, down 30.29% from the prior year.
- Short term Debt steadied at $206042.0 in Q2 2013 per COCP's latest filing, from $206040.0 in the prior quarter.
- Over five years, Short term Debt peaked at $284576.0 in Q3 2011 and troughed at $181752.0 in Q4 2012.
- A 4-year average of $230649.3 and a median of $227323.5 in 2011 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2012 and 2013: Short term Debt plunged 31.74% in 2012, then decreased 5.38% in 2013.
- Over 4 years, Short term Debt stood at $277299.0 in 2010, then dropped by 5.97% to $260741.0 in 2011, then slumped by 30.29% to $181752.0 in 2012, then rose by 13.36% to $206042.0 in 2013.
- According to Business Quant data, Short term Debt over the past three periods registered $206042.0, $206040.0, and $181752.0 for Q2 2013, Q1 2013, and Q4 2012 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.91 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.87 Bn | 59.68 Bn | 1.37 Bn |
| 4 | Moderna | 58.18 Bn | 53.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.96 Bn | 36.87 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.79 Bn | 9.40 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.37 Bn | 26.53 Bn | - |
| 10 | Cocrystal Pharma | 15.58 Mn | 13.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 206,042.00 |
| Mar 31, 2013 | 206,040.00 |
| Dec 31, 2012 | 181,752.00 |
| Sep 30, 2012 | 194,247.00 |
| Jun 30, 2012 | 217,755.00 |
| Mar 31, 2012 | 241,149.00 |
| Dec 31, 2011 | 260,741.00 |
| Sep 30, 2011 | 284,576.00 |
| Jun 30, 2011 | 236,892.00 |
| Dec 31, 2010 | 277,299.00 |